Related Experiment Video
Updated: Apr 15, 2026
08:49
Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry
Published on: January 12, 2012
22.6K
Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain
N D Volkow1, G-J Wang1, J Logan2
1Intramural Research Program, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA.
Translational Psychiatry
|April 15, 2015
Summary
Caffeine intake increases dopamine D2/D3 receptor availability in specific brain regions, not dopamine release. This change in receptor availability is linked to enhanced alertness, suggesting a mechanism for caffeine
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Caffeine is a widely consumed psychoactive substance.
- It promotes wakefulness and enhances alertness by influencing dopamine (DA) signaling.
- Caffeine's mechanism involves antagonizing adenosine A2A receptors (A2AR).
Purpose of the Study:
- To investigate if typical human caffeine doses increase DA release in the striatum.
- To determine if caffeine modulates postsynaptic DA receptor function via adenosine receptors.
- To assess caffeine's effect on DA D2/D3 receptor availability in healthy adults.
Main Methods:
- Positron emission tomography (PET) with [(11)C]raclopride, a DA D2/D3 receptor radioligand.
- Assessment of receptor availability in striatal subregions (putamen, ventral striatum, caudate).
- Comparison between caffeine (300 mg p.o.) and placebo conditions in 20 healthy controls.
Main Results:
- Caffeine significantly increased D2/D3 receptor availability in the putamen and ventral striatum, but not the caudate.
- No evidence of increased DA release; increased receptor availability suggests altered receptor levels or affinity.
- Increased D2/D3 receptor availability in the ventral striatum correlated with enhanced alertness.
Conclusions:
- Caffeine, at typical doses, increases DA D2/D3 receptor availability in the human striatum.
- This effect is not due to increased DA release but likely reflects changes in receptor levels or affinity.
- Upregulation of D2/D3 receptors in the ventral striatum may contribute to caffeine's arousal-enhancing effects.
More Related Videos
Related Concept Videos
01:29Stimulants
1.4K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.4K
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
1.4K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.4K
01:29Drugs Affecting Neurotransmitter Synthesis
2.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.6K
01:25Adrenergic Agonists: Indirect-Acting Agents
3.1K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
3.1K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.9K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.9K